Hyundai Bioscience Co. Ltd Capital Reinvestment Ratio
Hyundai Bioscience Co. Ltd capital reinvestment ratio. Hyundai Bioscience Co. Ltd (048410) has a Capital Reinvestment Ratio of 0.96x as of December 2024, meaning it reinvests 1% of its operating cash flow (₩2.26 Billion) in capital expenditures (₩2.17 Billion). Check Hyundai Bioscience Co. Ltd (048410) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Hyundai Bioscience Co. Ltd (2008–2024)
Capital reinvestment ratio of Hyundai Bioscience Co. Ltd from 2008 to 2024. This chart tracks Hyundai Bioscience Co. Ltd's Capital Reinvestment Ratio across 8 annual periods. Also explore Hyundai Bioscience Co. Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Hyundai Bioscience Co. Ltd Capital Reinvestment Ratio by Year (2008–2024)
Hyundai Bioscience Co. Ltd capital reinvestment ratio by year from 2008 to 2024. For the full cash flow conversion analysis, see Hyundai Bioscience Co. Ltd operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.96x | ₩2.26 Billion | ₩2.17 Billion | ▼ -71.4% |
| 2020 | 3.36x | ₩7.50 Billion | ₩25.20 Billion | ▲ +906.0% |
| 2019 | 0.33x | ₩9.18 Billion | ₩3.07 Billion | ▼ -76.3% |
| 2018 | 1.41x | ₩5.01 Billion | ₩7.07 Billion | ▼ -81.0% |
| 2015 | 7.41x | ₩87.36 Million | ₩647.57 Million | ▲ +980.0% |
| 2014 | 0.69x | ₩1.22 Billion | ₩840.18 Million | ▲ +917.4% |
| 2011 | 0.07x | ₩3.97 Billion | ₩267.78 Million | ▼ -82.1% |
| 2008 | 0.38x | ₩10.37 Billion | ₩3.92 Billion | — |